Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-035780
Filing Date
2022-10-03
Accepted
2022-10-03 16:15:42
Documents
14
Period of Report
2022-11-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20005311x4_def14a.htm DEF 14A 1633519
2 logo_tilraybrands.jpg GRAPHIC 108959
3 logo_tilraybrandsx1.jpg GRAPHIC 70238
4 ny20005311x4-pc_1a.jpg GRAPHIC 525823
5 ny20005311x4-pc_2a.jpg GRAPHIC 463609
6 ny20005311x4_butts.jpg GRAPHIC 56409
7 ny20005311x4_clanachan.jpg GRAPHIC 49877
8 ny20005311x4_herhalt.jpg GRAPHIC 48439
9 ny20005311x4_hopkinson.jpg GRAPHIC 38571
10 ny20005311x4_kennedy.jpg GRAPHIC 42185
11 ny20005311x4_looney.jpg GRAPHIC 51860
12 ny20005311x4_persofsky.jpg GRAPHIC 50558
13 ny20005311x4_robb.jpg GRAPHIC 38092
14 ny20005311x4_simon.jpg GRAPHIC 60039
  Complete submission text file 0001140361-22-035780.txt   3842373
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 001-38594 | Film No.: 221287655
SIC: 2833 Medicinal Chemicals & Botanical Products